Cleerly IPO

cleerlyhealth.com

Cleerly is the company creating a new standard of care for heart disease. Through value-based precision diagnostic solutions driven by machine intelligence, Cleerly enables comprehensive phenotyping of coronary artery disease, as determined from advanced non-invasive CT imaging.

Founded2017
Total Funding to Date$286.4MM
Register for Details

For more details on financing and valuation for Cleerly, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Cleerly Ticker Symbol

Cleerly does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Cleerly Stock Price

The stock price for Cleerly will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Cleerly Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
7/25/2022 Series C $230MM raised $XXX.XX $XXX.XX
6/21/2021 Series B and B-1 $44.9MM raised $XXX.XX $XXX.XX
8/10/2017 Series A $11.49MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Cleerly in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM